Industry Odisha Bureau, Aug 22: Zomato founder Deepinder Goyal has shared an update regarding ‘Temple,’ the wearable device being developed by his health-tech venture. He said that its latest version is less than half the size of the model shown previously.
In a post on X, Goyal said the device is now “the smallest wearable in the market” by volume. He also claimed that it is more powerful. However, he did not reveal the new dimensions or explain exactly how the company managed to reduce its size.
Notably, the wearable Temple is designed to track a metric called Entropy. The company describes this as an indicator of the metabolic and sympathetic demand placed on the body. The metric is intended to show how much physiological effort the body is under and how it responds to activities and recovery.
As per Goyal, Entropy is updated every second on an index ranging from 1 to 250. He says lower readings represent deeper rest. Meanwhile, higher levels are associated with intense physical or mental effort.
The device is designed to capture changes around the temple region of the head. Goyal has previously claimed that the company identified a biomarker in this area that can be used to estimate the body’s real time physiological demand.
He also shared internal testing comparing Entropic with a metabolic cart. Energy expenditure can be measured using this device. According to Goyal, Entropy showed a stronger correlation with the metabolic measurements than heart rate did across more than 100 cardio sessions. These claims, however, are based on the company’s reported testing and require independent validation.
Temple’s focus on brain-related measurements also need to be viewed carefully. Wearable sensors can detect signals linked to blood flow and oxygenation. Readings described as “cognitive load” do not by themselves diagnose brain fatigue, injury, or disease.
Goyal said the company wants to make Temple available once the device is ready. It has, however, not announced a launch date or final specifications.
